VanEck Biotech ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 3Y SHOWN · NET −$162M OVER THIS RANGE
Money keeps arriving — +$7M of net buying over the past month, about 1.5% of the fund's asset base, while the price has returned +26.8% so far this year. At 0.35% a year it is not the cheapest way in — IWM runs the same ground at 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS TODAY’S MOVE · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | AMGNAMGEN | 15.57% | $439.33 | +1.3% | ||
| 2 | GILDGILEAD SCIENCES | 12.45% | $146.12 | +1.9% | ||
| 3 | VRTXVERTEX PHARMACEUTICALS | 8.49% | $548.05 | +1.4% | ||
| 4 | REGNREGENERON PHARMACEUTICALS | 7.06% | $834.04 | +0.9% | ||
| 5 | MRNAMODERNA | 5.49% | $145.13 | +8.9% | ||
| 6 | NTRANATERA | 5.05% | $332.03 | +2.2% | ||
| 7 | RVMDREVOLUTION MEDICINES | 5.11% | $209.46 | -1.1% | ||
| 8 | IQVIQVIA HOLDINGS | 4.89% | $259.82 | +1.5% | ||
| 9 | ARGXARGENX SE | 4.77% | $1039.78 | +0.2% | ||
| 10 | ILMNILLUMINA | 3.30% | $219.40 | +2.9% | ||
| 11 | ONCBeiGene | 3.12% | $374.47 | +1.4% | ||
| 12 | BIIBBIOGEN | 3.08% | $216.78 | +1.1% | ||
| 13 | INSMINSMED | 2.69% | $125.77 | +0.6% | ||
| 14 | ALNYALNYLAM PHARMACEUTICALS | 2.50% | $236.22 | +3.0% | ||
| 15 | INCYINCYTE | 2.40% | $127.81 | +0.5% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 26| 1 week | +8.5% |
| 1 month | +18.5% |
| 3 months | +30.6% |
| 6 months | +22.4% |
| YTD | +26.8% |
| 1 year | +44.4% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$7M |
| 1 month | +$7M |
| 3 months | +$7M |
| YTD | −$120K |
| 1 year | −$28M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 15.6% of the book; the top ten carry 72%. Spread across 24+ names, it behaves like roughly 14 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $178M | $164M |
| TEM TEMPUS AI INC | $21M | $16M |
| AMGN AMGEN | $6M | $5M |
| ALNY ALNYLAM PHARMACEUTICALS | $3M | $3M |
| RVMD REVOLUTION MEDICINES | $2M | $3M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES